Showing results (1-10 of 156) with videos related to
Sort By:
Pageof 16
Therapeutic Innovation & Regulatory Science|September 7, 2021
Adverse Events in the Digital Age: Finding the Sharpest Tool in the BoxRobert Di Giovanni, Andrew Cochrane, David J LewisPharmacoepidemiology and Drug Safety|August 23, 2022
Adverse events in the digital age and where to find themRobert Di Giovanni, Andrew Cochrane, Jeremy Parker, et al.Paediatric Anaesthesia|May 22, 2004
Delayed rises in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypassDavid Lardner, Andrew Davidson, Ian McKenzie, et al.Chemical Communications (Cambridge, England)|May 7, 2014
Ambient pressure aerosol-assisted chemical vapour deposition of (CH₃NH₃)PbBr₃, an inorganic-organic perovskite important in photovoltaicsDavid J Lewis, Paul O'BrienTherapeutic Innovation & Regulatory Science|July 31, 2021
Implementation of a Pregnancy Prevention Programme (PPP) with a Controlled Distribution System (CDS) for the Generic Teratogenic Phthalimides Thalidomide, Lenalidomide and PomalidomideMarion Mueller, David J LewisScientific Reports|December 18, 2020
Thin films of formamidinium lead iodide (FAPI) deposited using aerosol assisted chemical vapour deposition (AACVD)Firoz Alam, David J LewisRSC Advances|May 6, 2022
Synthesis of indium oxide microparticles using aerosol assisted chemical vapour depositionFiroz Alam, David J LewisBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 22, 2006
Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapyHenry Ekert, Christian Brizard, Robert Eyers, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 6, 2010
Effectiveness and safety of high-dose valsartan monotherapy in hypertension treatment: the ValTop studyGianfranco Parati, Roland Asmar, Grzegorz Bilo, et al.Blood Pressure Monitoring|June 15, 2010
Use of automated blood pressure measurements in clinical trials and registration studies: data from the VALTOP StudyThomas Mengden, Roland Asmar, Albert Kandra, et al.Pageof 16